0000059478-23-000027.txt : 20230203 0000059478-23-000027.hdr.sgml : 20230203 20230203163509 ACCESSION NUMBER: 0000059478-23-000027 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ricks David A CENTRAL INDEX KEY: 0001538604 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 23586551 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 5 1 wf-form5_167546009467637.xml FORM 5 X0306 5 2022-12-31 0 0 0 0000059478 ELI LILLY & Co LLY 0001538604 Ricks David A LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 1 1 0 0 President, Chair, and CEO Common Stock 2022-08-15 5 G 0 32467 0 D 365316 D Common Stock 63500 I By David A. Ricks SLAT Common Stock 70000 I By David A. Ricks 2022 GRAT Common Stock 7169 I 401(k) The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. On May 11, 2022, the Reporting Person transferred 70,000 shares of Eli Lilly and Company common stock to a Grantor Retained Annuity Trust, of which the Reporting Person is the trustee. Exhibit 24 - Power of Attorney /s/ Jonathan Groff for David A. Ricks, pursuant to attached authorization 2023-02-03 EX-24 2 rickspoa.htm RICKS_POA_2022

David A. Ricks
Lilly Corporate Center
Indianapolis, Indiana  46285

Securities and Exchange Commission
Washington, D.C. 20549

Authorization Regarding Reporting Forms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 (including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company (the "Company") as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

Anat Hakim, Lilly Corporate Center, Indianapolis, Indiana

Christopher Anderson, Lilly Corporate Center, Indianapolis, Indiana

Jonathan Groff, Lilly Corporate Center, Indianapolis, Indiana

Valorie Wanner, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation revoke all prior authorizations and designations relating to reporting under Section 16 of the Securities Exchange Act of 1934 of the Company's securities and shall remain in effect until revoked by a subsequently filed instrument.

February 21, 2022

/s/ David A. Ricks